Yin, Hongping <br/><br/>
Fengycin inhibits the growth of the human lung cancer cell line 95D through reactive oxygen species production and mitochondria-dependent apoptosis.  [electronic resource] 

 -  Anti-cancer drugs  Jul 2013 
 - 587-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0b013e3283611395  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Calcium--metabolism<br/>Caspases--metabolism<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cyclin D1--metabolism<br/>Cyclin-Dependent Kinase 4--metabolism<br/>Flow Cytometry<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes, Neoplasm--drug effects<br/>Humans<br/>L-Lactate Dehydrogenase--biosynthesis<br/>Lipopeptides--pharmacology<br/>Lung Neoplasms--drug therapy<br/>Microscopy, Confocal<br/>Mitochondrial Membranes--metabolism<br/>Reactive Oxygen Species--metabolism